Arcturus Therapeutics Holdings Inc. ( ARCT) - Stock Earnings
ARCT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -13.4 million USD | 17.2 million USD |
| 2025Q4 | -29.1 million USD | 3.1 million USD |
| 2026Q1 | -27.0 million USD | 610000 USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ARCT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -29.7 million USD | 157.7 million USD |
| 2024 | -80.9 million USD | 138.4 million USD |
| 2025 | -65.8 million USD | 67.2 million USD |
| 2026 Est. | — | — |
ARCT
Price: $7.14
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.83 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 359653
Ebitda: -2.9 millionMarket Capitalization: 217.4 million